Much of that benefit is reported anecdotally and has not been confirmed in large, rigorous human trials
As the report observes, [t]he market share of Humira compared to its biosimilars is currently in a tenuous position, as manufacturers fiercely compete for preferred formulary positioning with pharmacy benefit managers (PBMs). MedBen currently offers the Humira biosimilar Idacio at a substantially reduced price, which will save clients nearly $3.3 million in 2024
The goal is to balance therapeutic benefit with tolerability
By encouraging your body to produce its own growth hormones, MK-677 supports natural, sustainable health improvements
It is important to note that while tirzepatide and semaglutide injections can be effective, they are not suitable for everyone
The SAE deemed unlikely related was in the placebo arm